The Food and Drug Administration recently expanded approval for Spravato, an antidepressant nasal spray used to treat ...

The U.S. Food and Drug Administration (FDA) approved the antidepressant nasal spray Spravato as a standalone treatment for depression in adults.

To qualify for treatment, patients must have a referral from a doctor or submit a self-referral form through Spravato’s or Parkside's websites.